References and Notes
<A NAME="RW13409ST-1A">1a</A>
Kolb HC.
Finn MG.
Sharpless KB.
Angew. Chem. Int.
Ed.
2001,
40:
2004
<A NAME="RW13409ST-1B">1b</A>
Bock VD.
Hiemstra H.
Maarseveen JH.
J. Org. Chem.
2006,
5:
919
<A NAME="RW13409ST-1C">1c</A>
Fournier D.
Hoogenboom R.
Schubert US.
Chem.
Soc. Rev.
2007,
36:
1369
<A NAME="RW13409ST-1D">1d</A>
Nandivada H.
Jiang X.
Lahann J.
Adv. Mater.
2007,
19:
2197
<A NAME="RW13409ST-1E">1e</A>
Lutz JF.
Angew. Chem. Int. Ed.
2007,
46:
1018
<A NAME="RW13409ST-1F">1f</A>
Tron GC.
Pirali T.
Billington RA.
Canonico PL.
Sorba G.
Genazzani AA.
Med.
Res. Rev.
2008,
28:
278
<A NAME="RW13409ST-1G">1g</A>
Hanelt S.
Liebscher J.
Synlett
2008,
1058
<A NAME="RW13409ST-2A">2a</A>
Rostovtsev VV.
Green LG.
Fokin VV.
Sharpless KB.
Angew. Chem. Int. Ed.
2002,
41:
2596
<A NAME="RW13409ST-2B">2b</A>
Tornoe
CW.
Christensen C.
Meldal M.
J. Org. Chem.
2002,
67:
3057
<A NAME="RW13409ST-2C">2c</A>
Zhang L.
Chen X.
Xue P.
Sun HHY.
Williams ID.
Sharpless KB.
Fokin VV.
Jia G.
J. Am. Chem.
Soc.
2005,
127:
15998
<A NAME="RW13409ST-2D">2d</A>
Rasmussen LK.
Boren BC.
Fokin VV.
Org. Lett.
2007,
9:
5337
<A NAME="RW13409ST-2E">2e</A>
Boren BC.
Narayan S.
Rasmussen LK.
Shang L.
Zhao H.
Lin Z.
Jia G.
Fokin VV.
J. Am. Chem. Soc.
2008,
130:
8923
<A NAME="RW13409ST-2F">2f</A>
Wu LY.
Xie YX.
Chen ZS.
Liu YN.
Liang
YM.
Synlett
2009,
1453
<A NAME="RW13409ST-2G">2g</A>
Yan ZY.
Wei HL.
Wu
LY.
Zhao YB.
Liang YM.
Tetrahedron: Asymmetry
2006,
17:
3288
<A NAME="RW13409ST-2H">2h</A>
Yan ZY.
Zhao YB.
Fan MJ.
Liu WM.
Liang YM.
Tetrahedron
2005,
61:
9331
<A NAME="RW13409ST-2I">2i</A>
Cristau HJ.
Cellier PP.
Spindler JF.
Taillefer M.
Chem.
Eur. J.
2004,
10:
5607
<A NAME="RW13409ST-3">3</A>
De O.
Ronaldo N.
Sinou D.
Srivastava RM.
J. Carbohydr. Chem.
2006,
25:
407
<A NAME="RW13409ST-4A">4a</A>
Andersen J.
Bolvig S.
Liang X.
Synlett
2005,
2941
<A NAME="RW13409ST-4B">4b</A>
Chan DCM.
Laughton CA.
Queener SF.
Stevens MFG.
Bioorg. Med. Chem.
2002,
10:
3001
<A NAME="RW13409ST-4C">4c</A>
Fletcher JT.
Walz SE.
Keeney ME.
Tetrahedron Lett.
2008,
49:
7030
<A NAME="RW13409ST-5A">5a</A>
Biagi G.
Livi O.
Scartoni V.
Verugi E.
Farmaco
1988,
43:
597
<A NAME="RW13409ST-5B">5b</A>
Haebich D.
Barth W.
Roesner M.
Heterocycles
1989,
29:
2083
<A NAME="RW13409ST-5C">5c</A>
Kadaba PK.
J. Org. Chem.
1992,
57:
3075
<A NAME="RW13409ST-5D">5d</A>
Sasaki T.
Eguchi S.
Yamaguchi M.
Esaki T.
J. Org. Chem.
1981,
46:
1800
<A NAME="RW13409ST-6">6</A>
Naud J.
Lemke C.
Goudreau N.
Beaulieu E.
White
PD.
Bioorg.
Med. Chem. Lett.
2008,
18:
3400
<A NAME="RW13409ST-7">7</A>
Broggini G.
De M I.
Martinelli M.
Paladino G.
Polati T.
Terraneo A.
Synthesis
2005,
2246
<A NAME="RW13409ST-8">8</A>
General Procedure
for the Synthesis of 2 (Conditions A)
To a flask were
added MeCN-H2O mixture (12 mL
v/v = 2:1),
azide (0.5 mmol), CuI (19 mg, 0.1 mmol), Na ascorbate (20 mg, 0.1
mmol), CaC2 (42 mg, 0.65 mmol). The mixture was stirred
at r.t., and the reaction was monitored by TLC. After reaction completed,
the system was neutralized to pH = 5
with aq HCl (6%), and the mixture was then extracted with
EtOAc (3 × 30 mL). The organic layer was separated, washed
with H2O and sat. brine, and dried over anhyd NaSO4.
Evaporation of the solvent gave the crude product, which was subjected
to column chromatography (silica gel, EtOAc-PE) to afford
1-substitued 1,2,3-triazoles 2.
<A NAME="RW13409ST-9">9</A>
General Procedure
for the Synthesis of 2 (Conditions B)
To a sealed
tube were added MeCN-H2O mixture (12 mL
v/v = 2:1),
azide (0.5 mmol), CuI (19 mg, 0.1 mmol), Na ascorbate (20 mg, 0.1
mmol), CaC2 (42 mg, 0.65 mmol). The mixture was stirred
at 90 ˚C, and the reaction was monitored by TLC. After
reaction completed, the system was neutralized to pH = 5
with aq HCl (6%), and the mixture was then extracted with
EtOAc (3 × 30 mL). The organic layer was separated, washed
with H2O and sat. brine, and dried over anhyd NaSO4.
Evaporation of the solvent gave the crude product, which was subjected
to column chromatography (silica gel, EtOAc-PE) to afford
1-substitued
1,2,3-triazoles 2.
<A NAME="RW13409ST-10">10</A>
All compounds gave satisfactory analytical
and spectral data.
Selected Data
(E)-1-[4-(2-Bromovinyl)phenyl]-1H-1,2,3-triazole (2j): yellow
solid, mp 147.8-148.1 ˚C. IR (KBr): 1599, 1511, 1435,
977, 783 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 8.00 (1
H, s), 7.85 (1 H, s), 7.73 (2 H, d, J = 9.0
Hz), 7.46 (2 H, d, J = 9.0
Hz), 7.16 (1 H, d, J = 13.8
Hz), 6.88 (1 H, d, J = 13.8 Hz). ¹³C
NMR (125 MHz, CDCl3): δ = 136.5,
136.4, 135.7, 134.5, 127.3, 121.5, 120.8, 108.3. ESI-MS: m/z (%) = 251(99) [M + 2]+,
249(100) [M+]. HRMS: m/z calcd for C10H8
79BrN3:
248.9902; found: 248.9906
(E)-1-[2-(2-Bromovinyl)phenyl]-1H-1,2,3-triazole (2k): yellow
solid, mp 100.9-101.5 ˚C. IR (KBr): 1609, 1496, 1507,
1447, 1193, 983, 783 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 7.89
(1 H, s), 7.80 (1 H, s), 7.59-7.57 (1 H, m), 7.52-7.46
(2H, m), 7.42 (1 H, d, J = 8.0
Hz), 6.84 (1 H, d, J = 14.0
Hz), 6.78 (1 H, d, J = 14.0
Hz). ¹³C NMR (125 MHz, CDCl3): δ = 134.3,
134.0, 131.7, 131.6, 130.1, 129.1, 127.1, 126.5, 125.7, 110.6. ESI-MS: m/z (%) = 251(99)
[M + 2]+,
249(100) [M+]. HRMS: m/z calcd for C10H8
79BrN3: 248.9902;
found: 248.9908.